SvAnna
SvAnna predicts the pathogenicity of structural variants (SVs) from long-read genome sequencing and prioritizes candidate SVs implicated in Mendelian diseases.
Key Features:
- Comprehensive Detection: Assesses all classes of structural variants to provide a genome-wide evaluation of SVs.
- Intersection Analysis: Evaluates intersections of SVs with transcripts and regulatory sequences to determine potential impacts on gene function.
- Clinical Correlation: Relates predicted effects on gene function to clinical phenotype data to support diagnostic interpretation.
- Prioritization Efficiency: Ranks deleterious SVs with 87% placed within the top ten candidate variants.
Scientific Applications:
- Genetic diagnostics: Prioritizes candidate SVs from long-read sequencing for diagnosis of Mendelian disorders.
- Mendelian disease research: Facilitates investigation of SV contribution to disease by linking SVs to transcriptomic and regulatory disruption.
Methodology:
Systematic assessment of structural variants across genomic contexts integrating transcriptomic and regulatory information with clinical phenotype data.
Topics
Details
- License:
- Not licensed
- Cost:
- Free of charge
- Tool Type:
- command-line tool
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- Java
- Added:
- 7/14/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Danis D, Jacobsen JOB, Balachandran P, Zhu Q, Yilmaz F, Reese J, Haimel M, Lyon GJ, Helbig I, Mungall CJ, Beck CR, Lee C, Smedley D, Robinson PN. SvAnna: efficient and accurate pathogenicity prediction of coding and regulatory structural variants in long-read genome sequencing. Genome Medicine. 2022;14(1). doi:10.1186/s13073-022-01046-6. PMID:35484572. PMCID:PMC9047340.
PMID: 35484572
PMCID: PMC9047340
Funding: - European Commission: 779257
- National Institutes of Health: 1R01HD103805-01